Skip to main content
. Author manuscript; available in PMC: 2020 Aug 5.
Published in final edited form as: Clin Cancer Res. 2017 May 22;23(17):5091–5100. doi: 10.1158/1078-0432.CCR-16-2540

Table 1.

Demographic and clinical characteristics stratified by premalignant lesion status.

Factor Overall (n=82) No Lesions (n=25) Lesions (n=50) P*
Age 62.9 (7.2) 64.5 (5.8) 62.2 (8.0) 0.16
Male 54/82 (65.9) 16/25 (64) 35/50 (70) 0.61
Current smoker 40/82 (48.8) 11/25 (44) 25/50 (50) 0.81
Pack-years 47.3 (15.7) 47.6 (17.9) 47.2 (15.2) 0.93
FEV1% Predicted 82.5 (18.6) 84.5 (17.9) 81.7 (19.2) 0.54
FEV1/FVC Ratio 71.2 (7.9) 73.4 (7.4) 69.6 (8.1) 0.05
COPD (FEV1%<80 & FEV1/FVC<70) 24/82 (29.3) 5/25 (20) 17/50 (34) 0.28
Histology <0.001
Normal 12/82 (14.6) 12/25 (48)
Hyperplasia 13/82 (15.9) 13/25 (52)
Metaplasia 7/82 (8.5)
Mild Dysplasia 35/82 (42.7) 35/50 (70)
Moderate Dysplasia 12/82 (14.6) 12/50 (24)
Severe Dysplasia 3/82 (3.7) 3/50 (6)

Data are means (SD) for continuous variables and proportions with percentages for dichotomous variables. P* values are for the comparison of subjects with and without premalignant lesions. Two sample t-tests were used for continuous variables: Fisher’s exact test was used for categorical variables.